Trend of indications for therapeutic plasma exchange at an Iranian university hospital (Q33394237)

26 July 2017

Trend of indications for therapeutic plasma exchange at an Iranian university hospital (English)

1 reference

26 July 2017

Shahrzad Shahidi

1

0 references

author name string

Mehrdad Memarzadeh

series ordinal

2

1 reference

PubMed ID

21334978

26 July 2017

Manijeh Kamali

series ordinal

3

1 reference

PubMed ID

21334978

26 July 2017

Afsoon Emami Naini

series ordinal

4

1 reference

26 July 2017

21 February 2011

1 reference

Transfusion and Apheresis Science

26 July 2017

1 reference

26 July 2017

44

1 reference

26 July 2017

2

1 reference

26 July 2017

119-122

1 reference

Spin doctors: new innovations for centrifugal apheresis

26 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

The Canadian Apheresis Group and therapeutic plasma exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Therapeutic apheresis in Canada. The Canadian Apheresis Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

International forum: France. The national survey of plasma exchange and therapeutic cytapheresis in France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

14 years of therapeutic plasma exchange in France.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

The International Apheresis Registry: results of 1983 second pilot.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Introduction to the third special issue: clinical applications of therapeutic apheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Apheresis technologies and clinical applications: the 2002 international apheresis registry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Apheresis registry in Sweden: scope, techniques and indications for treatment. A report from the Swedish apheresis study group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Apheresis in treatment of the inflammatory demyelinating peripheral neuropathies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Meta-analysis of clinical studies of the efficacy of plasma exchange in the treatment of chronic progressive multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Plasma exchange in France: Epidemiology 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Therapeutic plasma exchange: an update from the Canadian Apheresis Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Therapeutic apheresis in the Philippines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Plasmapheresis and subsequent pulse cyclophosphamide versus pulse cyclophosphamide alone in severe lupus: design of the LPSG trial. Lupus Plasmapheresis Study Group (LPSG).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Indications for plasma exchange in systemic lupus erythematosus in 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

Current status of therapeutic plasma exchange in Korea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2011.01.003

10.1016/J.TRANSCI.2011.01.003

7 January 2021

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

21334978